SOW
KNSA icon

State of Wyoming’s Kiniksa Pharmaceuticals KNSA Stock Holding History

State of Wyoming’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660K Sell
10,326
-2,650
-20% -$137K 0.07% 267
2026
Q1 		$625K Sell
12,976
-304
-2% -$13.5K 0.07% 217
2025
Q4 		$548K Buy
13,280
+5,318
+67% +$213K 0.06% 319
2025
Q3 		$309K Buy
+7,962
New +$259K 0.04% 676
2025
Q2 		– Sell
-17,064
Closed -$379K – 1982
2025
Q1 		$379K Buy
17,064
+2,258
+15% +$46.5K 0.05% 398
2024
Q4 		$293K Buy
+14,806
New +$338K 0.04% 581
2024
Q3 		– Sell
-3,893
Closed -$72.7K – 1805
2024
Q2 		$72.7K Buy
+3,893
New +$72.9K 0.01% 1213
2024
Q1 		– Sell
-2,342
Closed -$41.1K – 1736
2023
Q4 		$41.1K Buy
+2,342
New +$38.5K 0.01% 1394
2023
Q2 		– Sell
-8,231
Closed -$88.6K – 1675
2023
Q1 		$88.6K Buy
8,231
+1,071
+15% +$14.1K 0.03% 851
2022
Q4 		$107K Buy
7,160
+2,087
+41% +$30.4K 0.04% 703
2022
Q3 		$65K Buy
+5,073
New +$57.8K 0.03% 877
2022
Q1 		– Sell
-151
Closed -$2K – 1916
2021
Q4 		$2K Buy
+151
New +$1.86K ﹤0.01% 1774
2021
Q3 		– Sell
-235
Closed -$3K – 1277
2021
Q2 		$3K Buy
+235
New +$3.57K ﹤0.01% 1096

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

State of Wyoming's KNSA Position: Q2 2026 in Review

State of Wyoming reduced its Kiniksa Pharmaceuticals (KNSA) stake by 20% in Q2 2026, selling an estimated $137K and leaving 10,326 shares worth $660K. The position accounts for 0.07% of the portfolio, ranked #267.

State of Wyoming first reported a position in KNSA in Q2 2021 and has held it in 13 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • State of Wyoming held 10,326 shares of Kiniksa Pharmaceuticals worth $660K as of Q2 2026.
  • State of Wyoming sold 2,650 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $137K.
  • Kiniksa Pharmaceuticals made up 0.07% of State of Wyoming's portfolio in Q2 2026, its #267 holding.
  • State of Wyoming first reported a position in Kiniksa Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.